PLx Pharma Winddown Corp.

2020 Q4 Form 10-K Financial Statement

#000143774921005803 Filed on March 12, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2020 2019 Q4

Balance Sheet

Concept 2020 Q4 2020 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.45M $22.45M $14.00M
YoY Change 60.36% 60.36% -1.75%
Cash & Equivalents $22.45M $22.45M $14.00M
Short-Term Investments
Other Short-Term Assets $390.0K $390.0K $260.0K
YoY Change 50.0% 50.0% -56.67%
Inventory $143.0K $140.0K $0.00
Prepaid Expenses
Receivables $0.00 $0.00 $20.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $22.99M $22.99M $14.28M
YoY Change 60.93% 60.99% -3.92%
LONG-TERM ASSETS
Property, Plant & Equipment $1.226M $1.550M $1.467M
YoY Change -16.41% -25.48% 5.19%
Goodwill $2.061M $2.061M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $20.00K $20.00K $70.00K
YoY Change -71.43% -71.43% 0.0%
Total Long-Term Assets $3.631M $3.630M $4.219M
YoY Change -13.95% -13.98% 19.77%
TOTAL ASSETS
Total Short-Term Assets $22.99M $22.99M $14.28M
Total Long-Term Assets $3.631M $3.630M $4.219M
Total Assets $26.62M $26.62M $18.50M
YoY Change 43.85% 43.89% 0.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $860.0K $860.0K $930.0K
YoY Change -7.53% -7.53% 43.08%
Accrued Expenses $2.020M $2.020M $1.510M
YoY Change 33.77% 33.77% 29.06%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $622.0K $620.0K $3.658M
YoY Change -83.0% -83.06% 25.72%
Total Short-Term Liabilities $3.542M $3.540M $6.093M
YoY Change -41.87% -41.87% 28.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $622.3K
YoY Change -100.0% -85.46%
Other Long-Term Liabilities $134.0K $12.62M $409.4K
YoY Change -67.27% 23.48% 385.79%
Total Long-Term Liabilities $134.0K $12.62M $1.032M
YoY Change -87.01% 16.42% -76.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.542M $3.540M $6.093M
Total Long-Term Liabilities $134.0K $12.62M $1.032M
Total Liabilities $16.16M $16.16M $16.93M
YoY Change -4.54% -4.55% 41.77%
SHAREHOLDERS EQUITY
Retained Earnings -$102.1M -$86.94M
YoY Change 17.5% 30.86%
Common Stock $91.22M $74.85M
YoY Change 21.87% 2.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$10.93M $10.45M -$12.09M
YoY Change
Total Liabilities & Shareholders Equity $26.62M $26.62M $18.50M
YoY Change 43.85% 43.89% 0.62%

Cashflow Statement

Concept 2020 Q4 2020 2019 Q4

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-218150
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-12398
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9150568
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10026627
CY2020Q4 us-gaap Goodwill
Goodwill
2061022
CY2019Q4 us-gaap Goodwill
Goodwill
2061022
CY2019 plxp Increase Decrease In Bonuses And Severances
IncreaseDecreaseInBonusesAndSeverances
118428
CY2020 plxp Increase Decrease In Interest Payable Net Excluding Related Parties
IncreaseDecreaseInInterestPayableNetExcludingRelatedParties
60621
CY2019 plxp Increase Decrease In Interest Payable Net Excluding Related Parties
IncreaseDecreaseInInterestPayableNetExcludingRelatedParties
166984
CY2020 plxp Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-290997
CY2019 plxp Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-94376
CY2020Q4 plxp Interest Payable Noncurrent
InterestPayableNoncurrent
CY2019Q4 plxp Interest Payable Noncurrent
InterestPayableNoncurrent
501826
CY2020 plxp Net Income Loss Available To Common Stockholders Before Impact Of Preferred Stock Participation Rights
NetIncomeLossAvailableToCommonStockholdersBeforeImpactOfPreferredStockParticipationRights
-16947951
CY2019 plxp Net Income Loss Available To Common Stockholders Before Impact Of Preferred Stock Participation Rights
NetIncomeLossAvailableToCommonStockholdersBeforeImpactOfPreferredStockParticipationRights
-34253201
CY2020Q4 plxp Accrued Bonuses And Severances Current
AccruedBonusesAndSeverancesCurrent
1184823
CY2019Q4 plxp Accrued Bonuses And Severances Current
AccruedBonusesAndSeverancesCurrent
1166821
CY2020 plxp Beneficial Conversion Feature And Dividends Of Preferred Stock
BeneficialConversionFeatureAndDividendsOfPreferredStock
1737297
CY2019 plxp Beneficial Conversion Feature And Dividends Of Preferred Stock
BeneficialConversionFeatureAndDividendsOfPreferredStock
13750806
CY2020Q4 plxp Deferred Tax Assets And Liabilities Net
DeferredTaxAssetsAndLiabilitiesNet
31046039
CY2019Q4 plxp Deferred Tax Assets And Liabilities Net
DeferredTaxAssetsAndLiabilitiesNet
26734455
CY2020Q4 plxp Dividends Payable Noncurrent
DividendsPayableNoncurrent
2795795
CY2019Q4 plxp Dividends Payable Noncurrent
DividendsPayableNoncurrent
1058498
CY2020 plxp Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate And Other Percent
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRateAndOtherPercent
-0.283
CY2019 plxp Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate And Other Percent
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRateAndOtherPercent
-0.433
CY2020 plxp Effective Income Tax Rate Reconciliation Fair Value Of Derivatives Percent
EffectiveIncomeTaxRateReconciliationFairValueOfDerivativesPercent
-0.027
CY2019 plxp Effective Income Tax Rate Reconciliation Fair Value Of Derivatives Percent
EffectiveIncomeTaxRateReconciliationFairValueOfDerivativesPercent
-0.078
CY2020 plxp Increase Decrease In Bonuses And Severances
IncreaseDecreaseInBonusesAndSeverances
18002
CY2020 plxp Operating Loss Carryforwards Beginning Expiration Year
OperatingLossCarryforwardsBeginningExpirationYear
2035
CY2020 plxp Proceeds From Issuance Of Common Stock Net Issuance Costs
ProceedsFromIssuanceOfCommonStockNetIssuanceCosts
16819627
CY2019 plxp Proceeds From Issuance Of Common Stock Net Issuance Costs
ProceedsFromIssuanceOfCommonStockNetIssuanceCosts
2103788
CY2020Q4 plxp Working Capital
WorkingCapital
19400000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
862568
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
928921
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
448499
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
442882
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
91203050
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
74837046
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
875851
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1288430
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1300000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
900000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
91879
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
215292
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20300000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10500000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020Q4 us-gaap Assets
Assets
26616599
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13911633
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9156260
CY2017Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2646091
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Assets
Assets
18502746
CY2020Q4 us-gaap Assets Current
AssetsCurrent
22985501
CY2019Q4 us-gaap Assets Current
AssetsCurrent
14283255
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
12773
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22448651
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14001304
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22400000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14001304
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14250267
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22448651
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8447347
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-248963
CY2020Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
22400000
CY2017Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.50
CY2020 us-gaap Depreciation
Depreciation
124617
CY2019 us-gaap Depreciation
Depreciation
158253
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
124617
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
158253
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13911633
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9156260
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
13912
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
9156
CY2020Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
0
CY2019Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
0
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2020Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
600000
CY2020Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
143380
CY2019Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
3210579
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
7432665
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
215199
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
331231
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1101055
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1459313
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
598762
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
564880
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
31261288
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
27065686
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23118049
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
19381496
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
442731
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
637687
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2203211
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1966817
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4898535
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4514806
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
31046039
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
26734455
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
215199
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
331231
CY2020Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
17036
CY2019Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
73665
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
9691271
CY2019Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
8247679
CY2020 us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.74
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.84
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
9714951
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8916190
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.01
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
CY2020 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.018
CY2019 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.233
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.072
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.068
CY2020 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y182D
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4800000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1443592
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5710362
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2019Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2020Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2019Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15210654
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20502395
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-66353
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
448867
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18683
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
449
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
143380
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-304603
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-109716
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
73573
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-152714
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
307950
CY2019 us-gaap Interest Expense Debt
InterestExpenseDebt
589740
CY2020 us-gaap Interest Paid Net
InterestPaidNet
212856
CY2019 us-gaap Interest Paid Net
InterestPaidNet
600303
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
597411
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
34964
CY2020Q4 us-gaap Inventory Net
InventoryNet
100000
CY2019Q4 us-gaap Inventory Net
InventoryNet
0
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86938163
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
500000
CY2020 us-gaap Lease Cost
LeaseCost
107688
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
414065
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
262850
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
30132
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
60264
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
60819
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
38842
CY2020Q4 us-gaap Liabilities
Liabilities
16163564
CY2019Q4 us-gaap Liabilities
Liabilities
16933129
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26616599
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18502746
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3542314
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6093430
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
622265
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3658121
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
622265
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20792939
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-102148817
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2020 us-gaap Operating Expenses
OperatingExpenses
13489542
CY2019 us-gaap Operating Expenses
OperatingExpenses
14767757
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-13459112
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-14202293
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
350905
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
400000
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
400000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
327161
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
618158
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12640366
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-102000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-230294
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12243592
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12659035
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-15210654
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-20502395
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1751542
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6300102
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.095
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
97700000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
275247
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
304603
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
134184
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
409431
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
102000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
241736
CY2020 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1737297
CY2019 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1058498
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
930000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
930000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
393470
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
263268
CY2020 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Reclassifications</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Certain reclassifications have been made to the prior-year financial statements to conform to the current-year presentation.&nbsp; These reclassifications had <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on the reported results of operations.</div></div></div></div>
CY2020 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
11442
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1674378
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1909528
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1225879
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1466646
CY2020Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
CY2019Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
18683
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3750000
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3125000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4338974
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4741130
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
6444293
CY2020 us-gaap Sublease Income
SubleaseIncome
243217
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
30430
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
565464
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
7.52
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
714350
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1511000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
91475
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2074150
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1206709
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1666797
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2979047
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.93
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.96
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.35
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.76
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.03
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
1288430
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
875851
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1131314
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
17.34
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
254262
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
198750
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
9.78
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
15360
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y138D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y354D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y80D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y306D
CY2020 us-gaap Stock Issued1
StockIssued1
CY2019 us-gaap Stock Issued1
StockIssued1
45000
CY2019 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
45000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2103788
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
16819627
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-10931855
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-12091961
CY2020 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
CY2019 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
12692308
CY2019 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
CY2020 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The preparation of our consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying consolidated financial statements, estimates are used for, but <div style="display: inline; font-style: italic; font: inherit;">not</div> limited to, the impairment assessment of goodwill, the fair value of warrant liability, the fair value of stock-based compensation, allowance for inventory obsolescence, contingent liabilities, fair value and depreciable lives of long-lived assets, and deferred taxes and associated valuation allowance. Actual results could differ from those estimates.</div></div></div></div>
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
4311634
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
8891978
CY2017Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P10Y
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2019 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0

Files In Submission

Name View Source Status
0001437749-21-005803-index-headers.html Edgar Link pending
0001437749-21-005803-index.html Edgar Link pending
0001437749-21-005803.txt Edgar Link pending
0001437749-21-005803-xbrl.zip Edgar Link pending
ex_226884.htm Edgar Link pending
ex_226884img001.gif Edgar Link pending
ex_226885.htm Edgar Link pending
ex_226886.htm Edgar Link pending
ex_226887.htm Edgar Link pending
ex_226888.htm Edgar Link pending
ex_226889.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
plxp-20201231.xml Edgar Link completed
plxp-20201231.xsd Edgar Link pending
plxp-20201231_cal.xml Edgar Link unprocessable
plxp-20201231_def.xml Edgar Link unprocessable
plxp-20201231_lab.xml Edgar Link unprocessable
plxp-20201231_pre.xml Edgar Link unprocessable
plxp20201231_10k.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending